OLD National Bancorp IN purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 71,411 shares of the company's stock, valued at approximately $5,289,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bessemer Group Inc. grew its position in shares of GE HealthCare Technologies by 24.3% during the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company's stock valued at $538,000 after acquiring an additional 1,306 shares during the period. Flagship Harbor Advisors LLC boosted its position in GE HealthCare Technologies by 17.4% during the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company's stock worth $278,000 after purchasing an additional 511 shares in the last quarter. Lineweaver Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the second quarter valued at approximately $592,000. Wealth Enhancement Advisory Services LLC increased its position in shares of GE HealthCare Technologies by 23.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock valued at $4,105,000 after buying an additional 9,769 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its stake in shares of GE HealthCare Technologies by 52.7% during the 1st quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company's stock worth $357,000 after buying an additional 1,550 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.
GE HealthCare Technologies Stock Down 0.3%
Shares of GEHC opened at $76.56 on Monday. The company's 50-day moving average price is $74.25 and its 200 day moving average price is $72.48. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a market cap of $34.95 billion, a P/E ratio of 15.69, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same period last year, the business earned $1.00 earnings per share. The business's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the stock. Citigroup lifted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Weiss Ratings restated a "hold (c)" rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. Zacks Research lowered shares of GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 29th. Finally, Wall Street Zen lowered GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $86.89.
Read Our Latest Report on GE HealthCare Technologies
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.